1. Home
  2. CPSS vs PLX Comparison

CPSS vs PLX Comparison

Compare CPSS & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

N/A

Current Price

$9.49

Market Cap

204.6M

Sector

Finance

ML Signal

N/A

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.09

Market Cap

159.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
PLX
Founded
1991
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
159.5M
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
CPSS
PLX
Price
$9.49
$2.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
19.4K
669.9K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
1.27
N/A
EPS
0.24
0.22
Revenue
$434,470,000.00
$52,744,000.00
Revenue This Year
$147.09
$36.81
Revenue Next Year
N/A
N/A
P/E Ratio
$39.92
$9.32
Revenue Growth
10.41
N/A
52 Week Low
$6.67
$1.34
52 Week High
$10.49
$3.19

Technical Indicators

Market Signals
Indicator
CPSS
PLX
Relative Strength Index (RSI) 50.92 53.86
Support Level $9.40 $2.03
Resistance Level $9.66 $2.17
Average True Range (ATR) 0.34 0.06
MACD -0.05 0.01
Stochastic Oscillator 58.33 58.33

Price Performance

Historical Comparison
CPSS
PLX

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: